Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial

Gut. 2006 Jan;55(1):139-40. doi: 10.1136/gut.2005.081935.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Interferon-beta / therapeutic use*
  • Male
  • Middle Aged
  • Pilot Projects
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin
  • Interferon-beta